Filing Details

Accession Number:
0001628280-16-021749
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-01 10:57:57
Reporting Period:
2016-11-29
Filing Date:
2016-12-01
Accepted Time:
2016-12-01 10:57:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600132 Bellerophon Therapeutics Inc. BLPH Pharmaceutical Preparations (2834) 473116175
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1646754 Naseem Amin C/O Bellerophon Therapeutics, Inc.
184 Liberty Corner Road, Suite 302
Warren NJ 07059
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-29 714,285 $0.00 737,650 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2016-11-29 714,285 $0.00 714,285 $0.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
714,285 2016-11-29 2021-11-29 No 4 P Direct
Footnotes
  1. The reported securities are included within 714,285 Class A Units purchased by the reporting person for $0.70 per Class A Unit. Each Class A Unit consists of one share of common stock and one warrant to purchase one share of common stock